Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuyuki Kunihiro is active.

Publication


Featured researches published by Yasuyuki Kunihiro.


Journal of Cardiovascular Pharmacology | 1993

Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits

Masami Sato; Yukio Katsuki; Hideo Kanehiro; Midori Iimura; Yasushige Akada; Masahiro Mizota; Yasuyuki Kunihiro

The effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate (EPA-E) on in vivo physical properties of arteriosclerotic aorta and femoral artery in high cholesterol diet (HCD)-fed rabbits were studied. The aortic pulse wave velocity (PWV) of rabbits fed HCD for 12 weeks (control group) tended to be higher than that of rabbits fed a normal diet (normal group). Because the PWVs in HCD-fed rabbits administered orally with 30 and 300 mg/kg/day EPA-E were significantly lower than the PWV of the control group, the distensibility of arteriosclerotic aorta was improved with administration of EPA-E. The stiffness parameter (β) value as an in vivo indicator of arteriosclerosis was significantly higher in the control group than in the normal group and improved with administration of EPA-E to almost the same level as that of the normal group. The β-values were in significant negative correlation with medial elastin content and medial smooth muscle cell (SMC) density in thoracic aorta and in positive correlation with the free cholesterol content in abdominal aortic SMC. On the other hand, they were not correlated with either the cross-sectional area of intimal thickening lesions or the plasma lipid levels measured simultaneously. The femoral PWVs were, like those in the aorta, higher in the control group as compared with the normal group, and the changes were improved with administration of EPA-E. These results show that EPA-E improved the in vivo distensibility of arteriosclerotic arteries in HCD-fed rabbits. The mechanism of this improvement with EPA-E appeared to be related to histologic amelioration in the aortic medial elastic fibers and SMC and to protection from free cholesterol accumulation in SMC as one of the probable causes.


Archive | 1991

Thrombin composition for oral administration

Yasuyuki Kunihiro; Ryo Tanaka; Seishichi Hata; Koji Yamada


Archive | 1986

Thrombolytic composition and a process for production thereof

Michio Ichimura; Hidemi Ohta; Kiyoshi Sakai; Yasuyuki Kunihiro; Takehisa Nakashiro


Archive | 1994

Soluble thrombomodulin-containing composition

Yasuyuki Kunihiro; Ryo Tanaka; Seishichi Hata; Shigeharu Suzuki; Yumio Kudoh


Biological & Pharmaceutical Bulletin | 1993

Effects of Highly Purified Ethyl All-cis-5, 8, 11, 14, 17-icosapentaenoate (EPA-E) on Rabbit Platelets

Masami Sato; Yukio Katsuki; Kaoru Fukuhara; Hiroyuki Kawano; Masahiro Mizota; Yoshimasa Hamada; Yasuyuki Kunihiro


Archive | 1989

Anticoagulant substance obtained from urine

Yasuyuki Kunihiro; Ryo Tanaka; Michio Ichimura; Akio Uemura; Nobuo Ohzawa; Ei Mochida


Archive | 1989

ANTICOAGULANT SUBSTANCE OBTAINED FROM URINE AND PROCESS FOR THE PREPARATION THEREOF

Yasuyuki Kunihiro; Ryo Tanaka; Michio Ichimura; Akio Uemura; Nobuo Ohzawa; Ei Mochida


Archive | 1994

Composition containing soluble thrombomodulins

Yasuyuki Kunihiro; Ryo Tanaka; Shigeharu Suzuki


Archive | 1989

Urine-derived anticoagulant substance, its production and medical composition containing the same substance

Michio Ichimura; Yasuyuki Kunihiro; Suguru Mochida; Nobuo Osawa; Akira Tanaka; Akio Uemura


Archive | 1989

A novel thrombomodulin-like glycoprotein obtainable from urine

Yasuyuki Kunihiro; Ryo Tanaka; Michio Ichimura; Akio Uemura; Nobuo Ohzawa; Ei Mochida

Collaboration


Dive into the Yasuyuki Kunihiro's collaboration.

Top Co-Authors

Avatar

Ryo Tanaka

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Michio Ichimura

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Akio Uemura

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Seishichi Hata

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Ei Mochida

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Nobuo Ohzawa

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Shigeharu Suzuki

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hidemi Ohta

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kiyoshi Sakai

Mochida Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Koji Yamada

Mochida Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge